{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:50:07Z","timestamp":1785873007978,"version":"3.56.0"},"reference-count":39,"publisher":"American Academy of Pediatrics (AAP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"\n BACKGROUND:<\/jats:title>\n Antimicrobial stewardship programs (ASPs) have been proven to be beneficial in reducing the use of antimicrobial agents, antibiotic resistance, and health care costs. The data supporting the utility of ASPs has come largely from adult hospital units, but few pediatric hospital units have implemented ASPs. Our objective for this study was to assess the impact of ASPs in pediatric units in tertiary care teaching hospitals.<\/jats:p>\n <\/jats:sec>\n \n METHODS:<\/jats:title>\n We conducted a retrospective chart review to compare antimicrobial use pre- and post-ASP over a 6-month period in a tertiary care hospital in which an ASP had been in use since July 2017. Meropenem, vancomycin, and colistin were selected to be monitored. ASP rounds were conducted twice a week to assess and provide feedback on antimicrobial prescriptions. Antimicrobial use was measured as days of therapy (DOTs) per 1000 patient-days and was compared pre- and post-ASP by using independent t tests.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n Charts of children hospitalized who were in antimicrobial treatment pre-ASP (44.3%) and post-ASP (41.7%) were reviewed. The percentages of children who received selected antimicrobial agents did not differ between pre- and post-ASP. During the post-ASP period, a significant reduction in DOT with vancomycin and colistin was observed. Vancomycin use decreased from 58.5 to 40.2 DOTs per 1000 patient-days (P = .038), and colistin decreased from 36.3 to 13.8 DOTs per 1000 patient-days (P = .026). Meropenem use decreased from 126.8 to 111.2 DOTs per 1000 patient-days (P = .467). Between the 2 periods, there was no effect on length of stay and mortality.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS:<\/jats:title>\n ASPs can lead to a significant reduction in selected antimicrobial use in children who are hospitalized, with no effect on length of stay or mortality rate.<\/jats:p>\n <\/jats:sec>","DOI":"10.1542\/hpeds.2019-0027","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T13:15:20Z","timestamp":1572614120000},"page":"851-858","source":"Crossref","is-referenced-by-count":10,"title":["Impact of a Prospective Audit and Feedback Antimicrobial Stewardship Program in Pediatric Units in Tertiary Care Teaching Hospital in Thailand"],"prefix":"10.1542","volume":"9","author":[{"given":"Sineenart","family":"Chautrakarn","sequence":"first","affiliation":[{"name":"Preventive and Social Medicine, Faculty of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvaporn","family":"Anugulruengkitt","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Departments of Pediatrics and"},{"name":"Center of Excellence for Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyawee","family":"Puthanakit","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Departments of Pediatrics and"},{"name":"Center of Excellence for Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanapoom","family":"Rattananupong","sequence":"additional","affiliation":[{"name":"Preventive and Social Medicine, Faculty of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narin","family":"Hiransuthikul","sequence":"additional","affiliation":[{"name":"Preventive and Social Medicine, Faculty of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2019,11,1]]},"reference":[{"key":"2021120817065111400_B1","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Available at: www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf. Accessed July 18, 2016"},{"issue":"8","key":"2021120817065111400_B2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/605630","article-title":"Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship","volume":"49","author":"Roberts","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2021120817065111400_B3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3904\/kjim.2012.27.2.128","article-title":"Current epidemiology and growing resistance of gram-negative pathogens","volume":"27","author":"Livermore","year":"2012","journal-title":"Korean J Intern Med"},{"key":"2021120817065111400_B4","unstructured":"Centers for Disease Control and Prevention. National action plan for combating antibiotic-resistant bacteria. 2015. Available at: https:\/\/www.cdc.gov\/drugresistance\/pdf\/national_action_plan_for_combating_antibotic-resistant_bacteria.pdf. Accessed July 18, 2016"},{"key":"2021120817065111400_B5","unstructured":"European Center for Disease Prevention and Control; European Medicine Agency. Technical report: the bacterial challenge: time to react. 2009. Available at: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf. Accessed July 18, 2016"},{"issue":"3","key":"2021120817065111400_B6","first-page":"352","article-title":"Health and economic impacts of antimicrobial resistant infections in Thailand: a preliminary study","volume":"6","author":"Pumart","year":"2012","journal-title":"Journal of Health Services Research and Policy"},{"issue":"2","key":"2021120817065111400_B7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.idc.2016.02.001","article-title":"Overview: global and local impact of antibiotic resistance","volume":"30","author":"Watkins","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2021120817065111400_B8","unstructured":"Holloway\u2008K, van Dijk\u2008L. The World Medicines Situation 2011: Rational Use of Medicines. 3rd ed. Geneva, Switzerland: World Health Organization; 2011. Available at: www.who.int\/medicines\/areas\/policy\/world_medicines_situation\/WMS_ch14_wRational.pdf. Accessed July 18, 2016"},{"issue":"6","key":"2021120817065111400_B9","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1542\/peds.2010-1275","article-title":"Variability in antibiotic use at children\u2019s hospitals","volume":"126","author":"Gerber","year":"2010","journal-title":"Pediatrics"},{"issue":"4","key":"2021120817065111400_B10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/664761","article-title":"Rates and appropriateness of antimicrobial prescribing at an academic children\u2019s hospital, 2007-2010","volume":"33","author":"Levy","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"2021120817065111400_B11","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/jac\/dkv418","article-title":"The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children","volume":"71","author":"Versporten","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2021120817065111400_B12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/502486","article-title":"Evaluating vancomycin use at a pediatric hospital: new approaches and insights","volume":"26","author":"Bolon","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"2021120817065111400_B13","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archinte.163.8.972","article-title":"Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity","volume":"163","author":"Hecker","year":"2003","journal-title":"Arch Intern Med"},{"issue":"12","key":"2021120817065111400_B14","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/INF.0b013e3181b12484","article-title":"Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance","volume":"28","author":"Patel","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"2021120817065111400_B15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2021120817065111400_B16","first-page":"194","article-title":"Vital signs: improving antibiotic use among hospitalized patients","volume":"63","author":"Fridkin","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2021120817065111400_B17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.idc.2016.02.012","article-title":"The evolving role of antimicrobial stewardship in management of multidrug resistant infections","volume":"30","author":"Goff","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2021120817065111400_B18","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1093\/cid\/ciu543","article-title":"Antimicrobial stewardship: importance for patient and public health","volume":"59","author":"File","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2021120817065111400_B19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/j.1875-9114.2012.01155.x","article-title":"Antimicrobial stewardship in pediatric care: strategies and future directions","volume":"32","author":"Newland","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"3","key":"2021120817065111400_B20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/675277","article-title":"Prevalence and characteristics of antimicrobial stewardship programs at freestanding children\u2019s hospitals in the United States","volume":"35","author":"Newland","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"2021120817065111400_B21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/INF.0b013e3181d683f8","article-title":"Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital","volume":"29","author":"Di Pentima","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"2021120817065111400_B22","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1542\/peds.2010-3589","article-title":"Benefits of a pediatric antimicrobial stewardship program at a children\u2019s hospital","volume":"128","author":"Di Pentima","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"2021120817065111400_B23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/INF.0b013e318158603a","article-title":"Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital","volume":"27","author":"Metjian","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"2021120817065111400_B24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1542\/peds.2014-2579","article-title":"Antimicrobial stewardship programs in freestanding children\u2019s hospitals","volume":"135","author":"Hersh","year":"2015","journal-title":"Pediatrics"},{"issue":"3","key":"2021120817065111400_B25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jpids\/pis054","article-title":"Impact of a prospective-audit-with-feedback antimicrobial stewardship program at a children\u2019s hospital","volume":"1","author":"Newland","year":"2012","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"3","key":"2021120817065111400_B26","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1093\/jpids\/piy031","article-title":"Antimicrobial stewardship program in a pediatric intensive care unit","volume":"7","author":"Aizawa","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"9","key":"2021120817065111400_B27","doi-asserted-by":"crossref","first-page":"e00736-17","DOI":"10.1128\/AAC.00736-17","article-title":"Impact of a carbapenem antimicrobial stewardship program on patient outcomes","volume":"61","author":"Seah","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"2021120817065111400_B28","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/phar.1490","article-title":"Impact of an antimicrobial stewardship program on the use of carbapenems in a tertiary women\u2019s and children\u2019s hospital, Singapore","volume":"34","author":"Seah","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"3","key":"2021120817065111400_B29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12519-018-0133-y","article-title":"Introducing an antibiotic stewardship program in a pediatric center in China","volume":"14","author":"Zhang","year":"2018","journal-title":"World J Pediatr"},{"issue":"1","key":"2021120817065111400_B30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajic.2012.01.032","article-title":"National survey of antimicrobial stewardship programs in Thailand","volume":"41","author":"Khawcharoenporn","year":"2013","journal-title":"Am J Infect Control"},{"key":"2021120817065111400_B31","unstructured":"Center for Disease Control and Prevention. The core elements of hospital antibiotic stewardship programs. 2014. Available at: www.cdc.gov\/antibiotic-use\/healthcare\/pdfs\/core-elements.pdf. Accessed July 18, 2016"},{"key":"2021120817065111400_B32","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology; 2012. Available at: https:\/\/www.whocc.no\/filearchive\/publications\/1_2013guidelines.pdf. Accessed September 5, 2019"},{"issue":"4","key":"2021120817065111400_B33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s15010-017-1009-0","article-title":"Pediatric antibiotic stewardship: successful interventions to reduce broad-spectrum antibiotic use on general pediatric wards","volume":"45","author":"Kreitmeyr","year":"2017","journal-title":"Infection"},{"issue":"4","key":"2021120817065111400_B34","first-page":"339","article-title":"Reducing antimicrobial use in an academic pediatric institution: evaluation of the effectiveness of a prospective audit with real-time feedback","volume":"6","author":"Willis","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"2","key":"2021120817065111400_B35","first-page":"84","article-title":"Implementation and impact of an antimicrobial stewardship program at a non-freestanding children\u2019s hospital","volume":"23","author":"Klatte","year":"2018","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"1","key":"2021120817065111400_B36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.idc.2010.11.011","article-title":"Antimicrobial stewardship","volume":"25","author":"Tamma","year":"2011","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"2021120817065111400_B37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40506-014-0015-3","article-title":"Antimicrobial stewardship programs: appropriate measures and metrics to study their impact","volume":"6","author":"Morris","year":"2014","journal-title":"Curr Treat Options Infect Dis"},{"issue":"3","key":"2021120817065111400_B38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/PCC.0000000000000615","article-title":"Reduction of broad-spectrum antimicrobial use in a tertiary children\u2019s hospital post antimicrobial stewardship program guideline implementation","volume":"17","author":"Lee","year":"2016","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"2021120817065111400_B39","first-page":"e36","article-title":"Impact of an antimicrobial stewardship program on antibiotic use at a nonfreestanding children\u2019s hospital","volume":"6","author":"Turner","year":"2017","journal-title":"J Pediatric Infect Dis Soc"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/9\/11\/851\/815378\/hpeds_2019-0027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/9\/11\/851\/815378\/hpeds_2019-0027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T17:13:57Z","timestamp":1638983637000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/9\/11\/851\/26733\/Impact-of-a-Prospective-Audit-and-Feedback"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,1]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2019-0027","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,1]]}}}